Entrada Therapeutics
TRDA
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.66 | 0.03 | 0.69 | 104.55% |
| Revenue | 12.9M | 37.4M | 24.5M | 189.46% |
WhatIF - Earnings
EPS Beat Expectations by $0.69
Entrada Therapeutics (TRDA:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything